Results

• All
• Video
• Audio
• Images

• Most recent
• Filter by category

1–2 of 2 results for Christina Joy Flaxel

• 

  Phase 3 GUARD Trial of ADX-2191 (Methotrexate for Intravitreal Administration) to Prevent Proliferative Vitreoretinopathy and Other Postoperative Complications

  Christina Joy Flaxel, MD

  Annual Meeting Talks

  2023

• 

  Applying the DRCR.net Anti-VEGF Treatment Algorithm for Proliferative Diabetic Retinopathy: Neovascular Outcomes Over 2 Years

  Christina Joy Flaxel, MD

  Annual Meeting Talks

  2018